Different incidence of genotypic resistance to lamivudine in chronic hepatitis B between HBeAg and anti-HBe positive patients.

被引：0
|
作者：
Buti, M [1 ]
Cotrina, M [1 ]
Jardí, R [1 ]
Rodríguez, F [1 ]
Esteban, R [1 ]
Guàrdia, J [1 ]
机构：
[1] Univ Barcelona, Hosp Gen Valle Hebron, Liver Unit, Barcelona, Spain
来源：
HEPATOLOGY | 1998年 / 28卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1707
引用
收藏
页码：589A / 589A
页数：1
相关论文
共 50 条
  • [31] Incidence of HBeAg/anti-HBe and HBs/anti-HBs seroconversion after sntiviral treatment in children with chronic hepatitis B
    Kemnitz, P.
    Sluzewski, W.
    Mania, A.
    Figlerowicz, M.
    Kowala-Piaskowska, A.
    Michalak, M.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2010, 14 : E230 - E230
  • [32] Analysis of the complete hepatitis B virus genome in patients with genotype C chronic hepatitis in relation to HBeAg and anti-HBe
    Zhang, KaiYu
    Imazeki, Fumio
    Fukai, Kenichi
    Arai, Makoto
    Kanda, Tatsuo
    Mikata, Rintaro
    Yokosuka, Osamu
    JOURNAL OF MEDICAL VIROLOGY, 2007, 79 (06) : 683 - 693
  • [33] The natural history of Hbe Ag positive and anti-HBe positive chronic hepatitis B patients: A long term study.
    Lee, YM
    GASTROENTEROLOGY, 2002, 122 (04) : A305 - A305
  • [34] Natural history of chronic hepatitis B in the Chinese: Prognostic significance of HBeAg/anti-HBe positivity
    Yuen, MF
    Wong, WM
    Cheng, CC
    Wu, CH
    Wu, PC
    Lai, CL
    HEPATOLOGY, 1997, 26 (04) : 751 - 751
  • [35] The effect of lamivudine in Korean patients with anti-HBE/HBV DNA-positive chronic hepatitis B treated for 6 months.
    Choi, KW
    Kim, TN
    Lee, HJ
    HEPATOLOGY, 2000, 32 (04) : 588A - 588A
  • [36] INTERFERON THERAPY FOR THE ANTI-HBE POSITIVE FORM OF CHRONIC HEPATITIS-B
    ALBERTI, A
    FATTOVICH, G
    ANTIVIRAL RESEARCH, 1994, 24 (2-3) : 145 - 153
  • [37] DEMONSTRATION OF HBEAG, ANTI-HBE AND DANE PARTICLES IN SERUM OF HBS CARRIERS AND IN PATIENTS WITH CHRONIC HBSAG-POSITIVE HEPATITIS
    REICHLIN, B
    STALDER, GA
    GUDAT, F
    BIANCHI, L
    FROESNER, GG
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1982, 112 (15) : 523 - 524
  • [38] Lamivudine monotherapy and interferon plus lamivudine combination therapy in anti-HBe positive patients with chronic hepatitis B who have failed previously interferon treatment
    Akarca, US
    Ersoz, G
    Karasu, Z
    Gunsar, F
    Kilincsoy, N
    Batur, Y
    JOURNAL OF HEPATOLOGY, 2001, 34 : 167 - 167
  • [39] DETECTION OF HBEAG/ANTI-HBE IMMUNE-COMPLEXES IN THE REACTIVATION OF HEPATITIS-B VIRUS-REPLICATION AMONG ANTI-HBE CHRONIC CARRIERS
    CASTILLO, I
    BARTOLOME, J
    QUIROGA, JA
    PORRES, JC
    CARRENO, V
    LIVER, 1990, 10 (02): : 79 - 84
  • [40] Two years of lamivudine therapy in anti-HBe-positive patients with chronic hepatitis B
    Buti, M
    Cotrina, M
    Jardi, R
    de Castro, EC
    Rodriguez-Frias, F
    Sánchez-Avila, F
    Esteban, R
    Guardia, J
    JOURNAL OF VIRAL HEPATITIS, 2001, 8 (04) : 270 - 275
12345